A Cambridge startup called Vaxxas that’s developing vaccines worn on the skin as patches just raised a $20 million Series B. The funding will be used to bring its Nanopatch platform to clinical trial, and to flesh out its pipeline of needle-free vaccines. The Nanopatch works by riling up the immune cells just below the skin’s surface, inducing […]
In his TEDGlobal talk in Edinburgh, Scotland last summer, Mark Kendell listed four ways that a new delivery method could change the game for vaccines. His nanopatch uses microneedles instead of a syringe to deliver the treatment. Solving the “fear of needles” problem is a big deal but breaking the “cold chain” is a bigger […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.